{
  "retracted": false,
  "timestamp": 1567296000000,
  "updates": [
    {
      "timestamp": 1585250742627,
      "identifier": {
        "doi": "10.1016/j.ejca.2018.12.018"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ejca.2018.07.011"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to ‘A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours’ [Eur J Cancer 104 (November 2018) 1–8]"
}
